Synonyms|Editors|Languages|Comments|Home|Sponsors|Health Information| Editor Updates
|
|||||||||
|
|||||||||
| Causal
Agents: Protozoan hemoflagellates belonging to the complex Trypanosoma brucei. Two subspecies that are morphologically indistinguishable cause distinct disease patterns in humans: T. b. gambiense causes West African sleeping sickness and T. b. rhodesiense causes East African sleeping sickness. (A third member of the complex, T. b. brucei, under normal conditions does not infect humans.)
During a blood
meal on the mammalian host, an infected tsetse fly (genus Glossina)
injects metacyclic trypomastigotes into skin tissue. The parasites
enter the lymphatic system and pass into the bloodstream Geographic
Distribution: |
| Clinical
Features: Infection occurs in 3 stages. A trypanosomal chancre can develop on the site of inoculation. This is followed by a hemolymphatic stage with symptoms that include fever, lymphadenopathy, and pruritus. In the meningoencephalitic stage, invasion of the central nervous system can cause headaches, somnolence, abnormal behavior, and lead to loss of consciousness and coma. The course of infection is much more acute with T. b. rhodesiense than T. b. gambiense. Laboratory
Diagnosis:
Treatment: * This drug is approved by the FDA, but considered investigational for this purpose.
|